Neurotech International Limited (ASX:NTI)
0.0270
0.00 (0.00%)
Apr 24, 2025, 1:00 PM AEST
Neurotech International Revenue
Neurotech International had revenue of 113.72K AUD in the half year ending December 31, 2024, a decrease of -90.53%. This brings the company's revenue in the last twelve months to 80.48K, down -97.49% year-over-year. In the fiscal year ending June 30, 2024, Neurotech International had annual revenue of 3.18M with 166.00% growth.
Revenue (ttm)
80.48K
Revenue Growth
-97.49%
P/S Ratio
352.15
Revenue / Employee
n/a
Employees
n/a
Market Cap
28.34M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 3.18M | 1.98M | 166.00% |
Jun 30, 2023 | 1.19M | 586.87K | 96.59% |
Jun 30, 2022 | 607.62K | 401.25K | 194.44% |
Jun 30, 2021 | 206.37K | 126.03K | 156.86% |
Jun 30, 2020 | 80.34K | -165.49K | -67.32% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Telix Pharmaceuticals | 783.21M |
Ramsay Health Care | 17.12B |
Ansell | 3.00B |
Mesoblast | 9.16M |